The Importance of an Unbiased Safety Review Board in Phase I Clinical Trials

Abstract

Conducting clinical trials is the process that biopharmaceutical companies must use to demonstrate that their product is safe, well-tolerated, and efficacious to obtain marketing approval from the Food and Drug Administration (FDA)